Xintela AB: Xintela granted patent in Japan for XSTEM treatment of acute respiratory distress syndrome (ARDS)

Xintela (XINT) announces that the Japanese Patent Office (JPO) has granted a patent covering the company's stem cell product XSTEM® for the treatment of acute respiratory distress syndrome (ARDS) and ...
The Manila Times

Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma

Christopher Martin joins the Board of Directors, with Mark Zappia and Jim Willis joining as Senior Vice President of ...

CalciMedica, Inc.: CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates

FDA feedback on the Auxora pivotal program in acute pancreatitis and potential future development in acute kidney injury expected in 2Q 2026 Preclinical and IND-enabling ...
RMD Open

Clinical course, complications and treatment outcomes in Still’s disease: a 10-year single-centre cohort study

Objectives To evaluate the long-term outcomes, clinical phenotypes and factors associated with complications in Still’s ...